tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Atara Biotherapeutics reports Q3 EPS (32c), consensus (67c)

Reports Q3 revenue $3.45M, consensus $2.74M. The company said, “As previously communicated, Atara continues to actively explore and assess potential strategic alternatives with the goal of maximizing shareholder value.”

TipRanks Black Friday Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1